Hsa-miR-20b-5p and Hsa-miR-363-3p Affect Expression of and Tumor Suppressor Genes and Modulate Survival of T-ALL Cells In Vitro
Overview
Biophysics
Cell Biology
Molecular Biology
Authors
Affiliations
T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy arising from T lymphocyte precursors. We have previously shown by miRNA-seq, that miRNAs from the mir-106a-363 cluster are overexpressed in pediatric T-ALL. In silico analysis indicated their potential involvement in the regulation of apoptosis. Here, we aimed to test the hypothesis on the pro-tumorigenic roles of these miRNAs in T-ALL cells in vitro. We demonstrate, for the first time, that hsa-miR-20b-5p and hsa-miR-363-3p from the mir-106a-363 cluster, when upregulated in T-ALL cells in vitro, protect leukemic cells from apoptosis, enhance proliferation, and contribute to growth advantage. We show, using dual luciferase reporter assays, Ago2-RNA immunoprecipitation, RT-qPCR, and Western blots, that the oncogenic effects of these upregulated miRNAs might, at least in part, be mediated by the downregulation of two important tumor suppressor genes, and , targeted by both miRNAs. Additionally, we demonstrate the cooperative effects of these two miRNAs by simultaneous inhibition of both miRNAs as compared to the inhibition of single miRNAs. We postulate that hsa-miR-20b-5p and hsa-miR-363-3p from the mir-106a-363 cluster might serve as oncomiRs in T-ALL, by contributing to post-transcriptional repression of key tumor suppressors, and .
Adapted Exosomes for Addressing Chemotherapy-induced Premature Ovarian Insufficiency.
Mousaei Ghasroldasht M, Park H, Ali F, Beckman A, Mohammadi M, Hafner N Stem Cell Rev Rep. 2025; .
PMID: 39921838 DOI: 10.1007/s12015-024-10820-5.
MiR-363-3p induces tamoxifen resistance in breast cancer cells through PTEN modulation.
Liang Y, Shi C, Wang Y, Fan B, Song W, Shen R Sci Rep. 2024; 14(1):32135.
PMID: 39738797 PMC: 11685982. DOI: 10.1038/s41598-024-83938-8.
Chen L, Lai L, Zheng L, Wang Y, Lu H, Chen Y Transl Cancer Res. 2024; 13(2):1052-1067.
PMID: 38482429 PMC: 10928626. DOI: 10.21037/tcr-23-940.
Wang Y, Bai S, Zhang T, Liao C World J Gastrointest Oncol. 2023; 15(9):1556-1566.
PMID: 37746648 PMC: 10514722. DOI: 10.4251/wjgo.v15.i9.1556.
Fan M, Song W, Hao Z, Zhang J, Li Y, Fu J Medicine (Baltimore). 2023; 102(35):e34749.
PMID: 37657025 PMC: 10476739. DOI: 10.1097/MD.0000000000034749.